Darien, Connecticut – July 7, 2026 – United Health Products, Inc. (OTCQB: UEEC) today announced an agreement with NAMSA, the global leader in MedTech contract research offering end-to-end development services, whereby NAMSA will serve as regulatory sponsor of a new clinical study of UHP’s CelluSTAT Hemostatic Gauze. Consistent with the company’s recent proposal to the FDA to […]
Press Releases
United Health Products Provides Regulatory Update
Mount Laurel, New Jersey – April 6, 2026 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration (FDA) to resolve the Warning Letter issued on March 25, 2025, identifying violations that occurred during the company’s 2019 clinical trial. Following recent discussions, the FDA earlier […]
United Health Products Provides Corporate Update
Mount Laurel, New Jersey – December 15, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration (FDA) to resolve the Warning Letter issued on March 25, 2025, identifying certain violations of required clinical procedures that occurred during the company’s 2019 clinical trial. On […]
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com MT. LAUREL, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — United Health Products (OTCQB: UEEC), focused on the development and commercialization of innovative wound care technologies, today announced that Brian Thom, Chief Executive Officer, will present live at the Life Sciences […]
United Health Products Provides Regulatory Status Update
Mount Laurel, New Jersey – July 31, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration. As previously disclosed, the Company’s Investigational Device Exemption (IDE) application was disallowed pending resolution of the FDA Warning Letter issued on March 25, 2025, identifying certain violations […]
United Health Products Provides Regulatory Application Update
Mount Laurel, New Jersey – June 6, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA’s Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of […]